Clinical Immunology Service

Organisational unit: Department

Publications

  1. Published

    A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?

    Adrian Shields, 2012, In: Frontiers in immunology.

    Research output: Contribution to journalArticlepeer-review

  2. E-pub ahead of print
  3. Published

    A twist in the tale: epiploic appendagitis mimicking acute appendicitis.

    Adrian Shields, 30 May 2014, In: BMJ case reports. 2014, p. 1-2 2 p.

    Research output: Contribution to journalArticlepeer-review

  4. Published
  5. E-pub ahead of print
  6. Published
  7. E-pub ahead of print

    Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting

    Sylvie Freeman & 4 others, , 2 Apr 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  8. E-pub ahead of print
  9. E-pub ahead of print
  10. Published
  11. Published
  12. E-pub ahead of print
  13. Published
  14. Published
  15. Published
  16. Published

    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

    Sylvie Freeman & 4 others, , 1 Apr 2019, In: The Journal of Experimental Medicine. 216, 4, p. 966-981 16 p.

    Research output: Contribution to journalArticlepeer-review

  17. E-pub ahead of print
  18. Published
  19. E-pub ahead of print
  20. Accepted/In press
  21. E-pub ahead of print
  22. Published
  23. Accepted/In press
  24. Published

    Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels

    Jennifer Heaney, Alex Richter & Mark Drayson, Apr 2020, In: Haematologica. 105, 4, p. e169-e171 3 p.

    Research output: Contribution to journalLetterpeer-review

  25. Published
  26. Published
  27. E-pub ahead of print

    How to establish an academic SARS-CoV-2 testing laboratory

    Alex Richter, Thomas White, Jeremy Mirza & Alan McNally, 2 Nov 2020, (E-pub ahead of print) In: Nature Microbiology.

    Research output: Contribution to journalArticle

  28. E-pub ahead of print

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

    Sylvie Freeman, Oct 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  29. Published
  30. E-pub ahead of print

    In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser

    Adrian Shields, 18 Dec 2019, (E-pub ahead of print) In: Annals of Clinical Biochemistry.

    Research output: Contribution to journalArticlepeer-review

  31. Published
  32. E-pub ahead of print
  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
  38. Published

    MRD evaluation of AML in clinical practice: are we there yet?

    Sylvie Freeman, 6 Dec 2019, In: Hematology. 2019, 1, p. 557-569

    Research output: Contribution to journalArticlepeer-review

  39. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, 27 Feb 2020, In: Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticlepeer-review

  40. Published

    Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial

    Joanna Long, Mark Drayson, Angela Taylor, Kai Toellner, Janet Lord & Anna Whittaker, 23 May 2016, In: Vaccine. 34, 24, p. 2679-2685 7 p.

    Research output: Contribution to journalArticlepeer-review

  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
  50. Published

    Role of minimal (measurable) residual disease assessment in older patients with acute myeloid leukemia

    Sylvie Freeman, 1 Jul 2018, In: Cancers. 10, 7, 15 p., 215.

    Research output: Contribution to journalReview articlepeer-review

Previous 1 2 Next